Conditions: Type IIa and IIb Hypercholesterolaemia
Keywords: dyslipidemia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 668
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the efficacy and safety of Rosuvastatin 5 mg as an hypercholesterolemia treatment comparatively at 2 other statins: Pravastatin 40 mg and Atorvastatin 10 mg. Treatment efficacy will be evaluated by the percentage of LDL-C variation after 8 weeks of treatment.

Detailed description:

Arms:
arm 1: Rosuvastatin and Pravastatin arm 2: Rosuvastatin and Atorvastatin

Interventions: intervention 1: Rosuvastatin intervention 2: Pravastatin intervention 3: Atorvastatin
Intervention descriptions: intervention 1: 5mg oral intervention 2: 40mg oral intervention 3: 10mg oral

Protocol document: